NEOPLASIA MIELODISPLÁSICA (SMD) SECUNDÁRIA A LEUCEMIA LINFOCÍTICA CRÔNICA (LLC)

Autor: Puls, ML, Araujo, TFN, Souza, BA, Morais, CF, Moraes, PHA, Szor, RS, Liz, CD, Maia, ACA, Molla, VC, Silva, CAR

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S532-S533

SÍNDROME BING NEEL: RELATO DE CASO DE UMA COMPLICAÇÃO RARA

Autor: Malacarne, MA, Azevedo, MVA, Melo, FA, Grassi, LDV, Almeida, ICTS, Dias, JGF, Maia, ACA

Publikováno v: In Hematology, Transfusion and Cell Therapy October 2023 45 Supplement 4:S334-S334

Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin Lymphoma.

Autor: Santos FM; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil. fernanda.maria@hc.fm.usp.br., Marin JFG; Nuclear Medicine Medical Investigation Laboratory LIM43, Hospital das Clinicas, FMUSP (HCFMUSP), Sao Paulo-SP, Brazil., Lima MS; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Nuclear Medicine Medical Investigation Laboratory LIM43, Hospital das Clinicas, FMUSP (HCFMUSP), Sao Paulo-SP, Brazil., Silva-Junior WF; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil., Alves LBO; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil., Moreira FR; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil., Velasques RD; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil., Atanazio MJ; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil., Maia ACA; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil., Buchpiguel CA; Nuclear Medicine Medical Investigation Laboratory LIM43, Hospital das Clinicas, FMUSP (HCFMUSP), Sao Paulo-SP, Brazil., Buccheri V; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Division of Hematology, HCFMUSP, Sao Paulo-SP, Brazil., Rocha V; Instituto Do Cancer Do Estado de Sao Paulo (ICESP), Faculdade de Medicina, Universidade de Sao Paulo (FMUSP), Sao Paulo-SP, Brazil.; Division of Hematology and Cell Therapy, HCFMUSP, Sao Paulo-SP, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Internal Medicine, Division of Hematology, HCFMUSP, Sao Paulo-SP, Brazil.; Department of Hematology, Churchill Hospital, NHS BT, Oxford University, Oxford, UK.

Publikováno v: Annals of hematology [Ann Hematol] 2024 Jan; Vol. 103 (1), pp. 175-183. Date of Electronic Publication: 2023 Oct 05.

Consolidative mediastinal radiotherapy for advanced-stage classical Hodgkin lymphoma with bulky disease in patients who achieve complete response after chemotherapy in PET-CT era.

Autor: Atanazio MJ; Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Santos FM; Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Duran A; Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Maia ACA; Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Alves LB; Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Velasques RD; Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Rocha V; Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil., Buccheri V; Instituto do Cancer do Estado de São Paulo, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil.

Publikováno v: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology [Rep Pract Oncol Radiother] 2022 Oct 31; Vol. 27 (5), pp. 856-862. Date of Electronic Publication: 2022 Oct 31 (Print Publication: 2022).